These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 9517366)

  • 21. The impact of arteriovenous concentration differences on pharmacodynamic parameter estimates.
    Tuk B; Danhof M; Mandema JW
    J Pharmacokinet Biopharm; 1997 Feb; 25(1):39-62. PubMed ID: 9353693
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mathematical formalism and characteristics of four basic models of indirect pharmacodynamic responses for drug infusions.
    Krzyzanski W; Jusko WJ
    J Pharmacokinet Biopharm; 1998 Aug; 26(4):385-408. PubMed ID: 10214559
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrated functions for four basic models of indirect pharmacodynamic response.
    Krzyzanski W; Jusko WJ
    J Pharm Sci; 1998 Jan; 87(1):67-72. PubMed ID: 9452970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of four basic models of indirect pharmacodynamic responses.
    Dayneka NL; Garg V; Jusko WJ
    J Pharmacokinet Biopharm; 1993 Aug; 21(4):457-78. PubMed ID: 8133465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maxsim2 - Real-time interactive simulations for computer-assisted teaching of pharmacokinetics and pharmacodynamics.
    Gabrielsson J; Andersson K; Tobin G; Ingvast-Larsson C; Jirstrand M
    Comput Methods Programs Biomed; 2014 Mar; 113(3):815-29. PubMed ID: 24461798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetic/Pharmacodynamic Analysis of Metformin using Different Models in Diabetic Rats.
    Li X; Chen Y; Zhao Z; Lu W; Zhou T
    Drug Res (Stuttg); 2016 Oct; 66(10):547-554. PubMed ID: 27463030
    [No Abstract]   [Full Text] [Related]  

  • 27. Principles of pharmacodynamics and their applications in veterinary pharmacology.
    Lees P; Cunningham FM; Elliott J
    J Vet Pharmacol Ther; 2004 Dec; 27(6):397-414. PubMed ID: 15601436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology.
    Gabrielsson J; Green AR
    J Pharmacol Exp Ther; 2009 Dec; 331(3):767-74. PubMed ID: 19779129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methods of utilizing baseline values for indirect response models.
    Woo S; Pawaskar D; Jusko WJ
    J Pharmacokinet Pharmacodyn; 2009 Oct; 36(5):381-405. PubMed ID: 19697107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modeling delayed drug effect using discrete-time nonlinear autoregressive models: a connection with indirect response models.
    Xu XS; Wang H; Vermeulen A
    J Pharmacokinet Pharmacodyn; 2011 Jun; 38(3):353-67. PubMed ID: 21451962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of four basic models of indirect pharmacodynamic responses.
    Sharma A; Jusko WJ
    J Pharmacokinet Biopharm; 1996 Dec; 24(6):611-35. PubMed ID: 9300353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Algorithm for application of Fourier analysis for biorhythmic baselines of pharmacodynamic indirect response models.
    Krzyzanski W; Chakraborty A; Jusko WJ
    Chronobiol Int; 2000 Jan; 17(1):77-93. PubMed ID: 10672436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A regulatory perspective on pharmacokinetic/pharmacodynamic modelling.
    Machado SG; Miller R; Hu C
    Stat Methods Med Res; 1999 Sep; 8(3):217-45. PubMed ID: 10636336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expanding clinical applications of population pharmacodynamic modelling.
    Minto C; Schnider T
    Br J Clin Pharmacol; 1998 Oct; 46(4):321-33. PubMed ID: 9803979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Facilitation of drug evaluation in children by population methods and modelling.
    Tod M; Jullien V; Pons G
    Clin Pharmacokinet; 2008; 47(4):231-43. PubMed ID: 18336053
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of an indirect pharmacodynamic stimulation model of MX protein induction to compare in vivo activity of interferon alfa-2a and a polyethylene glycol-modified derivative in healthy subjects.
    Nieforth KA; Nadeau R; Patel IH; Mould D
    Clin Pharmacol Ther; 1996 Jun; 59(6):636-46. PubMed ID: 8681488
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethnic or racial differences revisited: impact of dosage regimen and dosage form on pharmacokinetics and pharmacodynamics.
    Chen ML
    Clin Pharmacokinet; 2006; 45(10):957-64. PubMed ID: 16984210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of a direct and indirect population pharmacodynamic model: application to recombinant human erythropoietin in athletes.
    Bressolle F; Audran M; Gareau R; Pham TN; Gomeni R
    J Pharmacokinet Biopharm; 1997 Jun; 25(3):263-75. PubMed ID: 9474529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population pharmacodynamic modeling of intramuscular and oral dexamethasone and betamethasone effects on six biomarkers with circadian complexities in Indian women.
    Krzyzanski W; Milad MA; Jobe AH; Peppard T; Bies RR; Jusko WJ
    J Pharmacokinet Pharmacodyn; 2021 Jun; 48(3):411-438. PubMed ID: 33954911
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delayed logistic indirect response models: realization of oscillating behavior.
    Koch G; Schropp J
    J Pharmacokinet Pharmacodyn; 2018 Feb; 45(1):49-58. PubMed ID: 29313194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.